Cipla launches CipAir®: AI-Powered App Revolutionizing Asthma Screening in India Kumar Jeetendra | December 18, 2024 Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced the launch of CipAir®️, a mobile application designed to enable timely and convenient first line of screening for asthma in India. This first-of-its-kind technology is clinically validated through a multi-centric pan-India study. It aims to empower people by helping them understand their …
The Power of Metabolomics & Multi-omics in Precision Science Kumar Jeetendra | February 12, 2026 Recent advances in precision science have abandoned the old-fashioned “one-size-fits-all” methodology. Researchers and clinicians have come to appreciate the importance of and need for considering the complexities of the entire biological system, rather than just focusing on a single layer of information. This is the point where metabolomics and multi-omics come into play. These are …
